Journal of Pharmaceutical Innovation

Papers
(The H4-Index of Journal of Pharmaceutical Innovation is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Editorial: Biopharmaceutical Innovation28
Development and Characterization of Copper Cross-Linked Freeze-Dried Bioscaffolds for Potential Wound Healing Activity24
Bioavailability Enhancement of Poorly Aqueous Soluble Atorvastatin Calcium by Solid Dispersion Technique Using a Modified Natural Polymer as a Hydrophilic Carrier24
Fabrication of Zein-Chitosan-Zein Sandwich-Like Nanofibers Containing Teicoplanin as a Local Antibacterial Drug Delivery System22
Gastroprotective Efficacy of Prebiotic-based Oral Formulation of Amoxicillin22
Baicalein-Loaded Aspasomal Formulations: Development, Characterization and Evaluation of Antioxidant and Anti-Inflammatory Effects21
Development of a Thermosensitive In-Situ Nasal Gel of Teriflunomide for Targeted CNS Delivery in Multiple Sclerosis18
Passive Targeted Drug Delivery of Venlafaxine HCl to the Brain by Modified Chitosan Nanoparticles: Characterization, Cellular Safety Assessment, and In Vivo Evaluation17
Co-delivery of Baicalin and Levofloxacin Via Chitosan Nanoparticles Synergistically Inhibits Pseudomonas aeruginosa PAO1 by Targeting Virulence Factors and Toxin-Associated Genes17
Lutein and β-Carotene Characterization in Free and Nanodispersion Forms in Terms of Antioxidant Activity and Cytotoxicity17
Novel Ketoconazole-Loaded Niosomal Gel with Carbamide for Enhanced Topical Delivery and Skin Hydration in Fungal Infections16
Hemoglobin-Polyvinyl Alcohol (Hb-PVA) Macroporous Cryogels As Swelling-Controlled Drug Delivery System Optimization and Release Kinetics of Vancomycin16
Albendazole-Para-Hydroxybenzoic Acid Cocrystals: A Lyophilization-Based Strategy for Enhanced Solubility and Therapeutic Performance16
A Novel Prednisolone-Loaded Layer-by-Layer Nanoparticles (LBL-NPs) for Rheumatoid Arthritis: Optimization and Therapeutic Evaluation15
A Multitargeted Approach to Breast Cancer Therapy: Exploring the Therapeutic Potential of Afzelin as a Combination Agent with FDA-Approved Breast Cancer Drugs15
Formulation and Cytotoxicity Assessment of Methylprednisolone Aceponate Microemulsions for Topical Delivery15
Accelerated Approval for Cancer Drugs in the United States and the Clinical Evidence Required for Conversion to Regular Approval15
0.29791808128357